Nicole Stankus
Section of Nephrology
Associate Professor of Medicine
Associate Director,Nephrology Fellowship Program; Medical Director, Stony Island Dialysis facility
Referring Physician Access Line: 1-877-DOM-2730


MD1989Vilnius University 
Residency1994Lutheran General HospitalInternal Medicine
Fellowship1996University of Illinois at ChicagoNephrology

Academic Interests

Dr. Stankus’ research interests focus on various aspects of end stage kidney disease, including current treatment methods for secondary hyperparathyroidism, prevention of bone and cardiac disease, new approaches in improving longevity of dialysis vascular access and prevention of systemic Staphylococcal infections in patients on hemodialysis. She also fosters a special interest in geriatric aspects of nephrology.

Clinical Interests

Care of patients with end stage kidney disease on hemodialysis and general consultative nephrology.

Representative Publications

  1. E. Lazar, K. Hebert, T. Poma, N. Stankus. Cinacalcet And Paricalcitol Titration Protocol Improves Long Term Treatment Outcomes In Secondary Hyperparathyroidism. Am J Nephrol 12;27(3):274-278, 2007
  2. N. Stankus, D. Gillen, M. Hammes, E. Worcester. African American ESRD patients have a high pre-dialysis prevalence of kidney stones compared to NHANES III. Urol Res 35(2):83-7, 2007
  3. E. Lazar, N. Stankus. Cinacalcet- Induced Hungry Bone Syndrome. Semin Dial 20(1): 83–85, 2007
  4. N. Stankus, E. Worcester, M. Hammes, F. L Coe. Evidence against a contribution of conventional urine risk factors to de novo ESRD renal stones. Nephrol Dial Transplant. 21(3):701-6, 2006

More Information

For more information about Dr. Nicole Stankus publications and research collaborations , please click here